Outcomes & Effectiveness
Inpatient Therapy and Outcomes in Acute Myeloid Leukemia
Unlike many solid tumors, treatment for acute myeloid leukemia (AML) is often urgent and provided in the inpatient setting. Not all patients receive aggressive therapy – due to age or underlying fitness for cytotoxic chemotherapy regimens. Little is known about patterns of inpatient AML treatment, complications, and short term mortality. This study will use detailed data from the Premier Perspectives database to characterize patterns of induction therapy, complications, and in-hospital mortality for AML. By triangulating with data from SEER-Medicare, we seek to develop population-level estimates of inpatient and outpatient treatment and outcomes.
Funding Source: Celgene Corporation
Principal Investigator: Xiaomei Ma